The South African Health Products Regulatory Authority (Sahpra) has issued a licence to GESlabs to manufacture cannabinoid pharmaceutical ingredients for use in therapeutic medicines. The company built a R20-million pharmaceutical laboratory in Cape Town, which will serve local, regional and international markets.
from Engineering News | Home https://ift.tt/33njTM2
